Soo Jung Park

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Ulcerative Colitis

Cancer Stem Cells

Patients With Inflammatory Bowel Disease

Top Venues

Yonsei medical journal

Journal of gastroenterology and hepatology

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong-Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park, null null
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study. Yonsei medical journal 65 (5) (2024)
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong-Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park, null null
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study. Yonsei medical journal 65 (5) (2024)
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong-Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park, null null
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study. Yonsei medical journal 65 (5) (2024)
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong-Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park, null null
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study. Yonsei medical journal 65 (5) (2024)
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong-Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park, null null
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study. Yonsei medical journal 65 (5) (2024)
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong-Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park, null null
Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study. Yonsei medical journal 65 (5) (2024)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease. Journal of gastroenterology and hepatology 39 (3) (2023)
Hye Kyung Hyun, Hye-Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do-Young Kim, Sang Hoon Ahn, Seung-Up Kim, Jae Hee Cheon
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease. Gut and liver (2023)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease. Journal of gastroenterology and hepatology (2023)
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei medical journal 64 (2) (2023)
Eun Jin Yoo, Sang-Hoon Cho, Soo Jung Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease. Yonsei medical journal 64 (9) (2023)
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei medical journal 64 (2) (2023)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease. Journal of gastroenterology and hepatology 39 (3) (2023)
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei medical journal 64 (2) (2023)
Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon
Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South Korea. Journal of gastroenterology and hepatology (2022)
Hee Seung Hong, Jiwon Baek, Jae Chul Park, Ho-Su Lee, Dohoon Park, A-Ran Yoon, Soo Jung Park, Sung Noh Hong, Seong-Joon Koh, Chang Kyun Lee, Bo In Lee, Sung Wook Hwang, Sang Hyoung Park, Seung-Jae Myung, Suk-Kyun Yang, Kyuyoung Song, Byong Duk Ye, null null
Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study. Gut and liver 16 (6) (2022)
Seong-Ran Jeon, Jin-Oh Kim, Seung Wook Hong, Dong-Hoon Yang, Bong Min Ko, Hyeon Jeong Goong, Hyun Joo Jang, Soo Jung Park, Eun Ran Kim, Sung Noh Hong, Jong-Pil Im, Seong Eun Kim, Ja Seol Koo, Chang-Soo Eun, Dong Kyung Chang, null null
Enteroscopy in Crohn's Disease: Are There Any Changes in Role or Outcomes Over Time? A KASID Multicenter Study. Gut and liver 15 (3) (2021)
Jung Won Park, Soo Yeon Chang, Joon Seok Lim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Byung Chang Kim, Tae Il Kim
Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer. Gut and liver (2021)
Jongwook Yu, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis. Gut and liver 15 (6) (2021)
Yong Il Lee, Ye Hyun Park, Soo Jung Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis. Gut and liver 15 (2) (2021)
Jongwook Yu, Hye Kyung Hyun, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence. Gut and liver (2021)
Ji Min Lee, Shu Chen Wei, Kang Moon Lee, Byong Duk Ye, Ren Mao, Hyun Soo Kim, Soo Jung Park, Sang Hyoung Park, Eun Hye Oh, Jong-Pil Im, Byeong Ik Jang, Dae Bum Kim, Ken Takeuchi
Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease. Gut and liver (2021)
Jongwook Yu, Soo Jung Park, Hyung Wook Kim, Yun Jeong Lim, Jihye Park, Jae Myung Cha, Byong Duk Ye, Tae Oh Kim, Hyun Soo Kim, Hyun Seok Lee, Su Young Jung, Youngdoe Kim, Chang Hwan Choi
Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study. Gut and liver 16 (5) (2021)
Ji Young Chang, Jae Hyun Kim, Joyeon Kang, Ye Hyun Park, Soo Jung Park, Jae Hee Cheon, Byung Chang Kim, Hoguen Kim, Jae Jun Park, Tae Il Kim
mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer. Yonsei medical journal 61 (7) (2020)
Hyun Jung Lee, Jae Hyeon Kim, Sujeong Hong, Inhwa Hwang, Soo Jung Park, Tae Il Kim, Won Ho Kim, Je-Wook Yu, Seung Won Kim, Jae Hee Cheon
Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet's disease. Scientific reports 9 (1) (2019)